ADAM PERUSKI: Open Payments
NPI 1558743096 · WEST BLOOMFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 101 payments from 29 companies in 2025. Trend: 2023 $1,790 · 2024 $2,604 · 2025 $2,189
Food & beverage: $2,189
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $259 |
| Abbott Laboratories | 20 | $256 |
| Amgen Inc. | 17 | $239 |
| Neurocrine BioSciences, Inc. | 2 | $161 |
| Ascendis Pharma Endocrinology Inc | 2 | $152 |
| Medtronic, Inc. | 1 | $130 |
| Corcept Therapeutics | 4 | $96 |
| Lilly USA, LLC | 5 | $89 |
| Ascensia Diabetes Care Us Inc. | 5 | $88 |
| ABBVIE INC. | 4 | $82 |
Products named: FREESTYLE LIBRE 3, TEPEZZA, CRENESSITY, Yorvipath, MINIMED 780G, Ozempic, Korlym, Wegovy.
Industry payments across MI — which companies pay providers there.
